Madrigal Pharmaceuticals (NasdaqGS:MDGL) faces an investigation into potential federal securities law violations tied to liver safety data for Rezdiffra. A whistleblower complaint alleges the company ...
Source LinkMadrigal Pharmaceuticals (NasdaqGS:MDGL) faces an investigation into potential federal securities law violations tied to liver safety data for Rezdiffra. A whistleblower complaint alleges the company ...
Source Link
Comments